Samuel N. Hazen, CEO at HCA Healthcare, Inc. (HCA), sold 42,877 shares at $502.95 ($21.5M) on 2026-02-03, disclosed to the SEC on 2026-02-05.
Seasonal sale ($21.5M) by CEO — this insider has traded HCA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $497.18 | 120 | $60K | 0.3% |
| 2 | $498.12 | 4,293 | $2.1M | 10.0% |
| 3 | $498.80 | 5,162 | $2.6M | 12.0% |
| 4 | $500.02 | 6,189 | $3.1M | 14.4% |
| 5 | $500.69 | 7,395 | $3.7M | 17.2% |
| 6 | $502.15 | 5,002 |
| $2.5M |
| 11.7% |
| 7 | $502.95 | 14,716 | $7.4M | 34.5% |
| Total | $501.04 avg | 42,877 | $21.5M | 100% |
| Filing → |
| HCA | SELL | 2018-02-02 | $5.6M | — | Filing → |
| HCA | SELL | 2015-04-17 | $14.4M | — | Filing → |
| HCA | SELL | 2014-12-29 | $13.5M | — | Filing → |